MedPath

Effect of sitagliptin on ectopic fat accumulation and glucose metabolism.

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000005666
Lead Sponsor
Juntendo University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Type 1 diabetes 2) Heavy alcohol drinker 3) Patients who have serious liver disease 4) Patients who have serious kidney disease 5) Patients who have serious heart disease ( patients who have apparent heartfailure or myocardial infarction within 3 months) 6) Patients who have serious pancreatic disease 7) Patients with cancer 8) Patients who have viral infection (HBV,HCV) 9) Patients with serious diabetic complications including progressed neutopathy and proliferative retinopathy 10) Patietns with serious infection, inflammation, or injuary. pre- or post- operative state 11) Patients who have inflammatory bowel disease, ulcer in bowel, ileus and high risk for ileus 12) Patients who are pregnant, hope to be pregnant, or are in lactation period 13) Patients who take pioglitazone 14) Patients who are not applicable to this study judged by the medical doctor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath